Cost-Effectiveness of Cetuximab for Advanced Esophageal Squamous Cell Carcinoma

BACKGROUND: Costly biologicals in palliative oncology are emerging at a rapid pace. For example, in patients with advanced esophageal squamous cell carcinoma addition of cetuximab to a palliative chemotherapy regimen appears to improve survival. However, it simultaneously results in higher costs. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Janmaat, Vincent T., Bruno, Marco J., Polinder, Suzanne, Lorenzen, Sylvie, Lordick, Florian, Peppelenbosch, Maikel P., Spaander, Manon C. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839693/
https://www.ncbi.nlm.nih.gov/pubmed/27100871
http://dx.doi.org/10.1371/journal.pone.0153943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839693/
https://www.ncbi.nlm.nih.gov/pubmed/27100871
http://dx.doi.org/10.1371/journal.pone.0153943

Ejemplares similares